KZR (STOCKS)
Kezar Life Sciences, Inc. Common Stock
$7.380000
+0.010000 (+0.14%)
Prev close: $7.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Christopher J. Kirk
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $54.55M
- Employees
- 55
- P/E (TTM)
- -0.97
- P/B (TTM)
- 0.77
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
3
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.99 | $-1.24 | -0.7435 | -59.89% |
|
Sep 2025 (Q3)
|
$-1.53 | $-2.10 | +0.5686 | +27.09% |
|
Jun 2025 (Q2)
|
$-1.87 | $-2.41 | +0.5426 | +22.49% |
|
Mar 2025 (Q1)
|
$-2.27 | $-2.63 | +0.3611 | +13.72% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $59.11M |
| Research and Development | $33.76M |
| Other Operating Expenses | $25.35M |
| Operating Income/Loss | -$59.11M |
| Income/Loss From Continuing Operations After Tax | -$56.03M |
| Income/Loss From Continuing Operations Before Tax | -$56.03M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$56.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$56.03M |
| Net Income/Loss Available To Common Stockholders, Basic | -$56.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.66 |
| Diluted Earnings Per Share | -$7.66 |
| Basic Average Shares | 7,316,890 |
| Diluted Average Shares | 7,316,890 |
| Assets | $76.65M |
| Current Assets | $75.73M |
| Noncurrent Assets | $915.00K |
| Fixed Assets | $166.00K |
| Other Non-current Assets | $749.00K |
| Liabilities | $6.57M |
| Current Liabilities | $6.57M |
| Accounts Payable | $507.00K |
| Wages | $66.00K |
| Other Current Liabilities | $6.00M |
| Noncurrent Liabilities | $0.00 |
| Equity | $70.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $70.07M |
| Liabilities And Equity | $76.65M |
| Net Cash Flow From Operating Activities | -$51.78M |
| Net Cash Flow From Operating Activities, Continuing | -$51.78M |
| Net Cash Flow From Investing Activities | $92.46M |
| Net Cash Flow From Investing Activities, Continuing | $92.46M |
| Net Cash Flow From Financing Activities | -$10.59M |
| Net Cash Flow From Financing Activities, Continuing | -$10.59M |
| Exchange Gains/Losses | $28.00K |
| Net Cash Flow | $30.13M |
| Net Cash Flow, Continuing | $30.10M |
| Comprehensive Income/Loss | -$55.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$55.87M |
| Other Comprehensive Income/Loss | -$55.87M |
| Other Comprehensive Income/Loss Attributable To Parent | $162.00K |